We found that KIAA1429 exhibited high levels of expression in DLBCL and increased m6A level of CHST11, thereby recruiting YTHDF2 to inhibit CHST11 stability and expression, resulting in promotion of DLBCL tumorigenesis. The gene discussed is VIRMA; the disease is diffuse large B-cell lymphoma.